Robert Carruthers

2.2k total citations
72 papers, 1.4k citations indexed

About

Robert Carruthers is a scholar working on Pathology and Forensic Medicine, Rheumatology and Oncology. According to data from OpenAlex, Robert Carruthers has authored 72 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pathology and Forensic Medicine, 19 papers in Rheumatology and 12 papers in Oncology. Recurrent topics in Robert Carruthers's work include Multiple Sclerosis Research Studies (43 papers), Systemic Lupus Erythematosus Research (12 papers) and Polyomavirus and related diseases (10 papers). Robert Carruthers is often cited by papers focused on Multiple Sclerosis Research Studies (43 papers), Systemic Lupus Erythematosus Research (12 papers) and Polyomavirus and related diseases (10 papers). Robert Carruthers collaborates with scholars based in Canada, United States and United Kingdom. Robert Carruthers's co-authors include Eleni T. Tzavara, Paul Greengard, Per Svenningsson, George G. Nomikos, Helen Tremlett, Feng Zhu, Elaine Kingwell, Anthony Traboulsee, Allen A. Fienberg and David L. McKinzie and has published in prestigious journals such as Science, Circulation and Journal of Neuroscience.

In The Last Decade

Robert Carruthers

64 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Carruthers Canada 18 583 379 292 275 213 72 1.4k
Cinzia Valeria Russo Italy 23 765 1.3× 178 0.5× 183 0.6× 131 0.5× 381 1.8× 61 1.3k
Antonio Carotenuto Italy 24 1.1k 2.0× 233 0.6× 242 0.8× 225 0.8× 422 2.0× 135 2.0k
Maria Donata Benedetti Italy 24 965 1.7× 366 1.0× 245 0.8× 284 1.0× 734 3.4× 68 2.0k
Davide Maimone Italy 25 658 1.1× 254 0.7× 186 0.6× 219 0.8× 469 2.2× 59 1.7k
Anneke van der Walt Australia 23 893 1.5× 172 0.5× 187 0.6× 111 0.4× 400 1.9× 142 1.5k
Ada Francia Italy 20 291 0.5× 334 0.9× 290 1.0× 430 1.6× 650 3.1× 59 1.5k
Ain Neuhaus United Kingdom 19 549 0.9× 258 0.7× 157 0.5× 70 0.3× 347 1.6× 38 1.4k
Jop Mostert Netherlands 26 1.1k 1.8× 282 0.7× 209 0.7× 225 0.8× 466 2.2× 72 1.8k
Omar Malik United Kingdom 19 637 1.1× 252 0.7× 161 0.6× 104 0.4× 253 1.2× 49 1.3k
Ayman Tourbah France 27 1.3k 2.2× 549 1.4× 363 1.2× 247 0.9× 664 3.1× 111 2.4k

Countries citing papers authored by Robert Carruthers

Since Specialization
Citations

This map shows the geographic impact of Robert Carruthers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Carruthers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Carruthers more than expected).

Fields of papers citing papers by Robert Carruthers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Carruthers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Carruthers. The network helps show where Robert Carruthers may publish in the future.

Co-authorship network of co-authors of Robert Carruthers

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Carruthers. A scholar is included among the top collaborators of Robert Carruthers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Carruthers. Robert Carruthers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uy, Christopher, et al.. (2026). A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Real-World Patient Cohort. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 1–9.
2.
Carruthers, Robert, et al.. (2024). Enhancing public health response: a framework for topics and sentiment analysis of COVID-19 in the UK using Twitter and the embedded topic model. Frontiers in Public Health. 12. 1105383–1105383. 6 indexed citations
3.
Sadovnick, A. Dessa, Maria Criscuoli, Irene M. Yee, et al.. (2024). Cesarian sections in women with multiple sclerosis: A Canadian prospective pregnancy study. Multiple Sclerosis Journal - Experimental Translational and Clinical. 10(4). 3110648746–3110648746.
4.
MacMillan, Erin L., Irene M. Vavasour, Christopher Harp, et al.. (2024). Resolution of glial activation in relapsing and primary progressive MS over 2 years with ocrelizumab: longitudinal MR spectroscopy study. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition. 1 indexed citations
5.
Vavasour, Irene M., Roger Tam, Cornelia Laule, et al.. (2022). Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head Images. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(1). 3080433960–3080433960. 6 indexed citations
6.
Vavasour, Irene M., Cornelia Laule, Roger Tam, et al.. (2022). Myelin heterogeneity for assessing normal appearing white matter myelin damage in multiple sclerosis. Journal of Neuroimaging. 33(2). 227–234. 2 indexed citations
7.
Woodhall, Mark, Bo Sun, Virginia Devonshire, et al.. (2021). Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort. Frontiers in Neurology. 11. 525933–525933. 13 indexed citations
8.
Wirth, Magdalena A., et al.. (2021). INVESTIGATING MICROANGIOPATHY USING SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH SUSAC SYNDROME. Retina. 41(10). 2172–2178. 2 indexed citations
9.
Bansback, Nick, et al.. (2021). Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(3). 3080393166–3080393166. 5 indexed citations
10.
Taylor, Carolyn, Roger Tam, Robert Carruthers, et al.. (2019). Effect of different doses of gadolinium contrast agent on clinical outcomes in MS. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(1). 2453243764–2453243764. 8 indexed citations
11.
Woodhall, Mark, Virginia Devonshire, Robert Carruthers, et al.. (2019). Myelin oligodendrocyte glycoprotein antibody-associated disease in a multi-ethnic Canadian cohort. Multiple Sclerosis Journal. 25. 810–811. 1 indexed citations
12.
Taylor, Carolyn, Ai‐Lan Nguyen, Virginia Devonshire, et al.. (2019). Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing–Remitting Multiple Sclerosis Patients. Journal of Neuro-Ophthalmology. 40(1). 37–43. 10 indexed citations
13.
Carruthers, Robert, Anthony Traboulsee, Ann Bass, et al.. (2019). Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings. Frontiers in Neurology. 10. 253–253. 14 indexed citations
14.
15.
Manouchehrinia, Ali, Helga Westerlind, Elaine Kingwell, et al.. (2017). Age Related Multiple Sclerosis Severity Score: Disability ranked by age. Multiple Sclerosis Journal. 23(14). 1938–1946. 102 indexed citations
16.
Kolind, Shannon, Irene M. Vavasour, Lisa Tang, et al.. (2017). Advanced Myelin-related MRI Measures in Relapsing Multiple Sclerosis Patients treated with Ocrelizumab or Interferon Beta-1a Over 96 Weeks (P6.371). Neurology. 88(16_supplement). 3 indexed citations
17.
Nguyen, Ai‐Lan, Janet Lam, Rick White, Robert Carruthers, & Anthony Traboulsee. (2016). Prospective study of Retinal Nerve Fibre Layer Thickness in Alemtuzumab Treated Multiple Sclerosis Patients (P3.083). Neurology. 86(16_supplement). 2 indexed citations
18.
Carruthers, Robert, Allan H. Ropper, & Adam B. Cohen. (2011). Dysautonomia From Bilateral Carotid Artery Dissection. Circulation. 123(25). 3009–3011. 2 indexed citations
19.
Carruthers, Robert & Ioanis Nikolaidis. (2005). Certain limitations of reputation--based schemes in mobile environments. 2–11. 14 indexed citations
20.
Kutney, James P., et al.. (1978). The chemistry of thujone. Bioorganic Chemistry. 7(3). 289–302. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cinzia Valeria Russo Breakdown of academic impact, for papers by Antonio Carotenuto Breakdown of academic impact, for papers by Maria Donata Benedetti Breakdown of academic impact, for papers by Davide Maimone Breakdown of academic impact, for papers by Anneke van der Walt Breakdown of academic impact, for papers by Ada Francia Breakdown of academic impact, for papers by Ain Neuhaus Breakdown of academic impact, for papers by Jop Mostert Breakdown of academic impact, for papers by Omar Malik Breakdown of academic impact, for papers by Ayman Tourbah
Rankless by CCL
2026